Neoadjuvant chemotherapy with CDDP and 5-fluorouracil for gastric cancer with serosal invasion

Oncology Reports

Volumn 10, Issue 2, 2003, Pages 433-438

  Takiguchi, Nobuhiro ^a   Nunomura, Masao ^a   Koda, Keiji ^a   Oda, Kenji ^a   Suzuki, Hirofumi ^a   Miyazaki, Masaru ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

5 FU; CDDP; Gastric carcinoma; Serosal invasion

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADJUVANT THERAPY; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; SEROSA; STOMACH TUMOR; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; SEROUS MEMBRANE; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0037810715     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.2.433     Document Type: Article

References (37)

1. Tateishi M, Ichiyoshi Y, Kawano T, Toda T, Minamisono Y and Nagasaki S: Recurrent pattern of digestive tract carcinoma in the Japanese: comparison of gastric cancer to colon cancer. Int Surg 80: 41-44, 1995.
2. Yoo CH, Noh SH, Shin DW, Choi SH and Min JS: Recurrence following curative resection for gastric cancer. Br J Surg 87: 236-242, 2000. (Pubitemid 30088655)
3. Koga S, Kaibara N, Iitsuka Y, Kudo H, Kimura A and Hiraoka H: Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients. J Cancer Res Clin Oncol 108: 236-238, 1984. (Pubitemid 14057507)
4. Boku T, Nakane Y, Minoura T, Takada H, Yamamura M, Hioki K and Yamamoto M: Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg 77: 436-439, 1990. (Pubitemid 20119386)
5. Bonenkamp JJ, Songun I, Hermans J and van de Velde CJ: The cooperative investigators of the Dutch Gastric cancer trial: prognostic value of positive cytology findings from abdominal washing in patients with gastric cancer. Br J Surg 83: 672-674, 1996. (Pubitemid 26163552)
6. Siewert JR and Fink U: Multimodale Therapiekonzepte bei Tumoren des Gastrointestinaltractes. Chirurgie 63: 242-246, 1992.
7. Preusser P, Wilke H, Achterrath W, Fink U, Lenaz L, Heinicke A, Meyer J, Meyer HJ and Buente H: Phase II study with combination etoposide, doxorubicin and cisplatin in advanced measurable gastric carcinoma. J Clin Oncol 7: 1310-1317, 1989, (Pubitemid 19220134)
8. Plukker JT, Mulder NH, Sleijfer DT, Grond J and Verschueren RC: Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br J Surg 78: 995-998, 1991.
9. Chung YS, Yamashita Y, Inoue T, Matsuoka T, Nakata B, Onoda N, Maeda K, Sawada T, Kato Y, Shirasaka T and Sowa M: Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma. Cancer 80: 1-7, 1997. (Pubitemid 27270913)
10. Japanese Research Society for Gastric Cancer: The General Rules for Gastric Cancer Study. 12th edition. Kanehara and Co., Ltd., Tokyo, 1998.
11. Japanese Research Society for Gastric Cancer: Japanese Classification of Gastric Carcinoma. 1st English edition. Kanehara and Co., Ltd., 1995.
12. Maruyama K, Okahayashi K and Kinoshita T: Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11: 418-422,1987.
13. Shiu MH, Moore E and Sanders M: Influence of the extent of resection on survival after curative treatment of gastric carcinoma. Arch Surg 122: 1347-1351, 1987. (Pubitemid 18021295)
14. Sasako M, McCulloch P, Kinoshita T and Maruyama K: New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82: 346-351, 1995.
15. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M and Stettner HM: A 10-year experience with Japanese-style radical lymph node dissection for gastric cancer outside of Japan. Cancer 76: 1302-1312, 1995.
16. Volpe CM, Koo J, Miloro SM, Driscoll DL, Nava HR and Douglass HO Jr: The effects of extended lymphadenectomy on survival in patients with gastric adenocarcinoma. J Am Coll Surg 181: 56-64, 1995.
17. Nakajima T, Ohra K and Ohyama K: Tabular analysis of CIH (Cancer Institute Hospital) database. In: Multimodality Therapy for Gastric Cancer. Nakajima T and Yamaguchi T (eds). Springer, New York, pp197-267, 1999.
18. Bleiberg H, Gerad B and Deguiral P: Adjuvant therapy in resectable gastric cancer. Br J Cancer 66: 987-992, 1992.
19. Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako M and van de Velde CJ: Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 11: 1441-1447, 1993. (Pubitemid 23228247)
20. Douglass HO Jr: Adjuvant therapy of gastric cancer: have we made any progress? Ann Oncol 5: 49-56, 1994.
21. Leach SD, Lowy AM, Mansfield PF and Ajani JA: Adjuvant therapy for resectable gastric adenocarcinoma: preoperative and postoperative chemotherapy trials. J Infus Chemother 5: 104-111, 1995.
22. Estape J, Grau JJ, Lcobendas F, Curto J, Daniels M, Vinolas N and Pera C: Mitomycin C as a adjuvant therapy to resected gastric cancer. Ann Surg 213: 219-221, 1991
23. Clark JL, Barcewicz P, Nava HR, Goodwin PS and Douglass HO Jr: Adjuvant 5-FU and MeCCNU improves survival following curative gastrectomy for adenocarcinoma. Am Surg 56: 423-427, 1990.
24. Wilke H, Preusser P, Fink U, Gunzer U, Meyer HJ, Meyer J, Siewert JR, Achterrath W, Lenaz L and Knipp H: Preoperative chemotherapy in locally advanced and non-resectable gastric cancer: a phase II study with etoposide, doxorubicin and cisplatin. J Clin Oncol 7: 1318-1326, 1989. (Pubitemid 19220135)
25. Shirasaka T, Shimamoto Y, Ohshima H, Saito H and Fukushima M: Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother Pharmacol 32: 167-172, 1993. (Pubitemid 23146807)
26. Lerner A, Gonin R, Steele GD Jr and Mayer RJ: Etoposide, doxorubicin and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial. J Clin Oncol 10: 536-540, 1992.
27. Kelsen D, Atiq OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale C, Vinciguerra V and Brennan M: FAMTX versus etoposide, doxorubicin and cisplatin: a random assignment trial in gastric cancer. J Clin Oncol 10: 541-548, 1992.
28. Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA and Rausch M: Modified therapy with 5-fluorouracil, doxorubicin and methotrexate in advanced gastric cancer. Cancer 72: 37-41, 1993. (Pubitemid 23182046)
29. Ajani JA, Roth JA, Ryan B, McMurtrey M, Rich TA, Jackson DE, Abbruzzese JL, Levin B, De Caro L and Mountain C: Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 8: 1231-1238, 1990. (Pubitemid 20195634)
30. Nakajima T, Ota K, Ishihara S, Oyama S, Nishi M, Ohashi Y and Yanagisawa A: Combined intensive chemotherapy and radical surgery for incurable gastric cancer. Ann Surg Oncol 4: 203-208, 1997. (Pubitemid 127725245)
31. Lightdale CJ: Endoscopic ultrasonography in the diagnosis, staging and follow-up of esophageal and gastric cancer. Endoscopy 24: 297-303, 1992.
32. Aibe T, Fujimura H, Yanai H, Okita K and Takemoto T: Endosonographic diagnosis of metastatic lymph nodes in gastric carcinoma. Endoscopy 24: 315-319, 1992.
33. Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, Fushida S, Fujimura T, Nishimura G and Miwa K: Intraperitoneal lavage for cytological examination in 1297 patients with gastric carcinoma. Am J Surg 178: 256-262, 1999. (Pubitemid 29475109)
34. Ribeiro U Jr, Gama-Rodrigues JJ, Safatle-Ribeiro AV, Bitelman B, Ibrahim RE, Ferreira MB, Laudanna AA and Pinotti HW: Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer. J Gastrointest Surg 2: 244-249, 1998. (Pubitemid 128409610)
35. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma. 13th edition. Kaneahra and Co., Ltd., Tokyo, 1998.
36. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma. 2nd English edition. Gastric Cancer 1: 10-24, 1998.
37. Kondo K, Murase M, Kodera Y, Akiyama S, Ito K, Yokoyama Y, Takagi H and Shirasaka T: Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer. Oncology 53: 64-67, 1996. (Pubitemid 26027092)